Sacubitril / Valsartan tablet bulk supplier for pharma manufacturers

Sacubitril / Valsartan Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg

Reference Brands: Entresto: (US and EU)

Sacubitril + Valsartan tablets combine an angiotensin receptor blocker with a neprilysin inhibitor, boosting natriuretic peptides and reducing blood pressure. They improve heart failure symptoms, decrease hospitalizations, and enhance survival rates. Benefits include better cardiac function, reduced strain, and improved quality of life for heart failure patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Sacubitril + Valsartan tablets, marketed as Entresto, are approved in the US by the FDA and in the EU via EMA for heart failure with reduced ejection fraction. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and post-market surveillance plans. In the US, the FDA reviews detailed clinical trial and quality data, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance supports timely approval, safe use, and global availability of sacubitril/valsartan tablets, helping improve outcomes for heart failure patients worldwide.

Sacubitril / Valsartan Tablet — third party manufacturing & bulk supply

Sacubitril / Valsartan Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sacubitril / Valsartan Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sacubitril / Valsartan Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sacubitril / Valsartan Tablet →

Back to Listing

Frequently Asked Questions

Sacubitril / valsartan is used to treat chronic heart failure with reduced ejection fraction (HFrEF). It helps reduce the risk of cardiovascular death and hospitalization related to heart failure by improving heart function and blood circulation.

Sacubitril / valsartan is a combination of two active components: sacubitril, a neprilysin inhibitor that increases beneficial peptides that relax blood vessels, and valsartan, an angiotensin II receptor blocker (ARB) that lowers blood pressure by preventing blood vessel narrowing.

The main trade name of sacubitril / valsartan is Entresto. Another trade name available in some regions is Vymada.

The original brand Entresto is developed and marketed by Novartis, while several pharmaceutical companies manufacture approved versions in different countries.

The generic name of the product is sacubitril / valsartan.

The most recognized brand name of sacubitril / valsartan is Entresto.

Sacubitril / valsartan is manufactured in multiple countries including the United States, European countries, India, and other global pharmaceutical manufacturing regions by licensed pharmaceutical manufacturers.